Form 4: Lemaitre Vascular Inc. Executive Reports Dividend Equivalent Rights Acquisition

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, acquired dividend equivalent rights related to previously granted stock awards.

Summary

• Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit and performance share unit awards.
• The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of the company's common stock.
• The transactions occurred on December 5, 2024, and are related to awards granted between 2019 and 2023.
• The total number of dividend equivalent rights acquired is 5.9036, which are linked to common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively by investors. There are no indications of negative sentiment.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of executive compensation with shareholder value.
• The vesting schedule of the rights is tied to the underlying stock awards, promoting long-term performance.

Industry Context

This filing is a routine disclosure of executive compensation and is typical for publicly traded companies. It reflects standard practices for aligning executive interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• The use of dividend equivalent rights is a common practice in executive compensation packages, particularly in the technology and healthcare sectors.
• Companies like Medtronic and Boston Scientific also use similar equity-based compensation methods to incentivize their executives.
• The vesting schedules tied to underlying stock awards are also standard practice to ensure long-term alignment of interests.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns executive interests with shareholder value, potentially benefiting shareholders.
• The vesting schedule of the rights promotes long-term performance, which can positively impact the company's overall success.

Key Dates

Keywords

dividend equivalent rights, Lemaitre Vascular, stock awards, executive compensation, Form 4, insider trading, restricted stock units, performance share units